Vice President, Ophthalmology Medical Affairs

Company: 

At Annexon Biosciences we are a biopharmaceutical company advancing a late-stage clinical platform of novel therapies for people living with devastating classical complement-mediated neuroinflammatory diseases of the body, brain, and eye. Our novel scientific approach targets upstream C1q to block the classical complement inflammatory cascade before it starts, and its therapeutic candidates are designed to provide meaningful benefits across multiple autoimmune, neurodegenerative and ophthalmic diseases. With proof-of concept data in Guillain-Barré syndrome, Huntington’s disease and geographic atrophy, we are rigorously advancing our mid-to late-stage clinical trials to bring new potential treatments to patients as quickly as possible. At Annexon, you’ll be part of a team committed to making an impact together.   

For more information on Annexon and our pipeline, check out our site Annexon Biosciences & Annexon Pipeline. We trade on Nasdaq under the ticker symbol ANNX and are headquartered in Brisbane, CA. 

We're seeking exceptional talent from all backgrounds to fuel our growth. At Annexon, we're building a diverse, equitable, and inclusive workplace. We value unique perspectives and unconventional paths. If you're the best candidate for the job, even if you don't perfectly fit the traditional mold, we encourage you to apply. Learn more about our commitment to diversity, equity, inclusion, and our company culture! 

Position: 

The Vice President, Ophthalmology Medical Affairs will be responsible for representing Annexon Biosciences with a network of external thought leaders and driving Global Medical Affairs activities in complement-mediated diseases in Ophthalmology.

Responsibilities include: 

• As a key member of the ophthalmology core team, provide deep medical and scientific expertise on medical affairs, launch, and lifecycle strategies.
• Lead the full spectrum of the Medical Affairs functions that are responsible for the development and implementation of the Global medical strategy across the following areas:
  • Medical Affairs Operations – focused on communication, medical education, advisory management, and patient advocacy.
  • Medical Science Liaison – directed at work with practicing physicians, key opinion leaders, academic physicians, and other health care providers who deliver care to the targeted patient population